Binaifer Balsara

Binaifer Balsara is an accomplished clinical development professional with extensive experience in the field of oncology. Currently serving as Executive Director of Clinical Development at Kura Oncology, Inc. since May 2019, Binaifer has also held various roles at ImmunoGen, Inc. and Novartis, contributing significantly to clinical trials and research. Binaifer's previous experience includes serving as a Clinical Research Review Specialist at Rutgers Cancer Institute of New Jersey and as a Research Associate at Fox Chase Cancer Center. Binaifer possesses a Ph.D. in Applied Biology from Bombay University and has a track record of managing complex clinical trials, ensuring compliance with regulatory standards, and aiding in the development of innovative treatment protocols.